909.60MMarket Cap-8126P/E (TTM)
14.6050High13.1200Low746.78KVolume13.9200Open13.9600Pre Close10.27MTurnover1.72%Turnover RatioLossP/E (Static)67.43MShares19.050052wk High2.67P/B584.90MFloat Cap2.050052wk Low--Dividend TTM43.36MShs Float85.0000Historical High--Div YieldTTM10.64%Amplitude0.0300Historical Low13.7530Avg Price1Lot Size
Perspective Therapeutics Stock Forum
Larger Image: tradingview.com...
$Perspective Therapeutics (CATX.US)$
$Perspective Therapeutics (CATX.US)$
1:10
$Virgin Galactic (SPCE.US)$ 1:20
$Star Equity (STRR.US)$ 1:5
$Workhorse (WKHS.US)$ 1:20
FDA Selects Perspective Therapeutics To Participate In The CDRP Program To Expedite Chemistry, Manufacturing, and Controls Development Readiness For VMT-α-NET in Neuroendocrine Tumors
The Zhitong Finance App learned that the market value of the Richland, Washington-based company has increased about four times this year to reach US$833 million. Amid the radiopharmaceuticals (also...
No comment yet